Acute Inflammatory Response - StatPearls - NCBI Bookshelf 13/02/22, 18:45

Acute Inflammatory Response

Hannoodee S, Nasuruddin DN.

Introduction
Inflammation is part of the innate defense mechanism of the body against infectious or non-infectious etiologies. This mechanism is
non-specific and immediate.[1] There are five fundamental signs of inflammation that include: heat (calor), redness (rubor), swelling
(tumor), pain (dolor), and loss of function (functio laesa). Inflammation can divide into three types based on the time of the process that
responds to the injurious cause; acute which occurs immediately after injury and lasts for few days, chronic inflammation that may last
for months or even years when acute inflammation fails to settle, and subacute which is a transformational period from acute to chronic
which lasts from 2 to 6 weeks.[2]

Acute inflammation starts after a specific injury that will cause soluble mediators like cytokines, acute phase proteins, and chemokines
to promote the migration of neutrophils and macrophages to the area of inflammation.[3] These cells are part of natural innate immunity
that can take an active role in acute inflammation. If this inflammation does not resolve after six weeks, this will cause the acute
inflammation to develop from subacute to the chronic form of inflammation with the migration of T lymphocytes and plasma cells to the
site of inflammation. If this persists with no recovery, then tissue damage and fibrosis will ensue. Other varieties of cells, such as
macrophages and monocytes, play a role in both acute and chronic inflammation. In this article, we will discuss "acute inflammation."

Issues of Concern
Acute inflammation is an immediate, adaptive response with limited specificity caused by several noxious stimuli, such as infection and
tissue damage (tissue necrosis). The controlled inflammatory response is generally beneficial, and this can be seen clearly in providing
protection against infectious organisms, including mycobacterium tuberculosis, protozoa, fungi, and other parasites. However, it can
become detrimental if not regulated, such as seen in septic shock.[4] The inflammatory pathway consists of a sequence of events
involving inducers, sensors, mediators, and effectors.[5]

The process will initiate in the presence of inducers, which can be infectious organisms or non-infectious stimuli such as foreign bodies
and signals from necrotic cells or damaged tissues. This will, in turn, activate the sensors, which are specialized molecules. The sensors
will then stimulate the mediators, which are endogenous chemicals that can induce pain, activate or inhibit inflammation and tissue
repair, and can activate the effectors, which are the tissues and cells.[6] These players can act together and give rise to multiple
alternative pathways in the inflammatory process, depending on the type of stimuli. The goal of the inflammatory process is to restore
homeostasis regardless of the cause.[4]

Causes
The causes or inducers of inflammation can classify into two main groups: exogenous and endogenous inducers.[4]

1. Exogenous inducers.

This grouping can further subdivide into two classes; microbial and non-microbial exogenous inducers.

A. Microbial inducers.

There are two classes of microbial inducers. The first class is pathogen-associated molecular patterns (PAMPs), which are carried by all
microorganisms. The second class is virulence factors restricted to pathogens. Virulence factors trigger the inflammatory response due
to the effects of their activity. Examples include enzymatic activity produced by helminths and exotoxins produced by bacteria, which
will be sensed by known or unknown sensors.

B. Non-Microbial

Causes include allergens, toxic compounds, irritants, and foreign bodies that are too large to be digested or cause phagosomal damage in

https://www.ncbi.nlm.nih.gov/books/NBK556083/ Página 1 de 5
Acute Inflammatory Response - StatPearls - NCBI Bookshelf 13/02/22, 18:45

macrophages. Examples of foreign bodies include silica and asbestos.

2. Endogenous inducers.

These are signals released by tissues that are either dead, damaged, malfunctioned, or stressed.

As an alternative, we could also divide the inflammatory inducers into two large groups, which are the infectious factors and the non-
infectious factors.

I. Infectious factors:

This category includes bacteria, viruses, and other microorganisms.

II. Non-Infectious factors:

This group can be due to physical injuries such as frostbite, burn, physical injury, foreign bodies, trauma, ionizing radiation,
chemical compounds such as glucose, fatty acids, toxins, alcohol, and chemical irritants such as nickel and other trace elements. Apart
from that, there are also biological inducers, including signals released by damaged cells and physiological due to excitement.[7]

Biochemical and Genetic Pathology

Many mediators play a crucial role in initiating the cascade in the acute inflammatory process. The first group of mediators is the toll-
like receptors (TLRs), which are membrane-spanning proteins found on the surfaces of the innate immune system cells like
macrophages and dendritic cells. These single-pass membrane-spanning receptors recognize the pathogen-associated molecular patterns
(PAMPs) or can recognize endogenous signals activated during tissue or cell damage known as danger-associated molecular patterns
(DAMPS). To date, research has identified more than ten TLRs. An important example is the CD14 (cluster of differentiation 14), a co-
receptor for TLR4, which is present on the surface of innate immune system cells preferentially expressed in macrophages, monocytes,
and neutrophils. TLR4 can recognize the Lipopolysaccharide, which is the major component of the outer membrane of the gram-
negative bacteria (PAMPs). Then the transmission of PAMPs and DAMPs are mediated by MyD88 (myeloid differentiation 88) along
with the TLRs. Subsequently, the signaling will transmit through a specific cascade that leads to nuclear translocation of transcription
factors, such as NF-kB, activator protein-1 (AP-1), or interferon regulatory factor 3(IRF3).[7][8][9]

The second groups of mediators are arachidonic acid (AA) mediators. Arachidonic acid is a phospholipid that constitutes the membrane
of the body's cells. Phospholipase can become activated by inducers, such as infection or tissue damage. This enzyme can act on this
membrane phospholipids to liberate the arachidonic acid. This component can potentially metabolize into two main components through
either the cyclooxygenase pathway or the 5-lipooxygenase pathway. The cyclooxygenase pathway forms the prostaglandins (PG)
mediators; this includes the PGD2 and thromboxane, which are the bronchoconstrictive prostaglandins and the bronchoprotective or
inhibitory PGE2 and prostacyclin. On the other hand, the 5-lipooxygenase pathway will form the leukotrienes (LTs). Examples of LTs
include LTB4, which is neutrophil adhesive and chemotactic, LTC4, D4, and E4, which is involved in contraction of smooth muscle
bronchioles, vasoconstriction, and edema formation.[10]

The third group of mediators are the Mast cells, derived from precursors in the bone marrow and widely distributed in the connective
tissue. These cells will become activated by tissue damage. Other immune molecules also contribute to the activation of these
molecules, including the C3a and C5a, which lead to degranulation of human mast cells. Mast cells can also be enhanced by cross-
linking of their high-affinity receptors for IgE. After activation, mast cell secretes a few pro-inflammatory molecules such as histamine,
TNF, kinin, and leukotrienes (Leukotrienes play an important role in the delayed response of acute inflammation caused by mast cell
activation).[11]

The fourth group of mediators that can activate the acute inflammation is the Complements. The complements are a set of proteins that
interact with one another to create a cascade. A large number of these complements can become activated through several pathways like
the classical, alternative, or mannose-binding lectin pathway. The most important complement in acute inflammation include the C3a
and C5a that mediate the anaphylatoxins, and also the C5a consider as chemotactic for neutrophils, C3b for opsonin for phagocytosis.
These complements can then activate the MAC (membrane attack complex) that can activate the neutrophils, monocyte, and mast cells.

https://www.ncbi.nlm.nih.gov/books/NBK556083/ Página 2 de 5
Acute Inflammatory Response - StatPearls - NCBI Bookshelf 13/02/22, 18:45

[12][13]

The last mediators are the Hageman factor, which is a part of clotting factors and also plays an important role in inflammation.
Activation of this factor will lead to the activation of the kinin system and the formation of bradykinin. Bradykinin increases the
permeability of the walls of blood vessels. This leakage leads to the swelling considered as part of the acute inflammation.[14][15]

Other mediators and biomarkers of acute inflammation include Reactive oxygen and reactive nitrogen oxide species (ROS and RNOS),
cytokines such as IL-6, TNF-alpha, and chemokines, the formation of DNA adducts, acute-phase proteins such as C-reactive protein
(CRP), inflammation-related growth factors and transcription factors (NF-KappaB) and major immune cell types. The type of the
mediators and immune cells involved all are variable and depend on several factors like the type of inducer, the duration of the injury,
and multiple genetic loci.[16]

Clinicopathologic Correlations
Cardiovascular Disease and Acute Inflammation

Cardiovascular diseases, including atherosclerosis, are recognized as the most common cause of death worldwide. During the formation
of atherosclerosis, the inflammatory mediators play a principal role in the initial cell recruitment until the rupture of the plaque. Cardiac
stress, due to any reason, will first appear as inflammation. In affected cardiac tissues, there are elevated levels of inflammatory
chemokines and cytokines synthesis and release. In cardiac injury, the most immediate defense mechanism against any cardiac tissue
damage is innate immunity. Coronary atherosclerosis is the most common cause of myocardial infarction that results in cardiac tissue
loss. In myocardial infarction, as the cardiac cells die and become necrotic, the inflammatory cells would start to come to the site of the
necrotic tissue to clear the dead cells and debris. Cell death is the inducer that triggers the acute inflammation process resulting in the
release of endogenous signals recognized as a danger signal. Subsequently, the TLRs-mediated pathways trigger inflammatory
responses by activating the NF-kB pathway. Next, the chemokines recruit the leukocytes to the areas of the infarct, and the cytokines
allow the adhesion between leukocytes and endothelial cells. TGF-B and IL-10 promote cardiac repair by suppressing inflammation.[7]

Pancreas and Acute Inflammation

Acute pancreatitis is an inflammatory disease of the pancreas caused by either pancreatic duct obstruction, gene mutation, or
alcoholism. Acute pancreatitis is among the most common causes of hospitalization in the United States. Inflammation in acute
pancreatitis occurs by activation of neutrophils and granulocytes, which secrete inflammatory cytokines. NF-kB, JAK-STAT, and
MAPK pathways play an important role in cell activation during pancreatitis.[17]

Liver and Acute Inflammation

The liver is the largest internal human body organ. As the inflammation is a protective mechanism by the body, it will protect the liver
from infection and injury, but if this occurs extensively, this will cause hepatocytes injury, metabolic changes, ischemia-reperfusion
trauma, and constant hepatic impairment. Acute inflammation of the liver can develop to damage the parenchyma of the liver, and if it
persists, this will turn to chronic hepatitis. The inducer of liver inflammation involves both the non-infectious and infectious
pathologies. The infectious agent includes the Hepatitis B virus (HBV) and Hepatitis C virus (HCV), while the non-infectious agent
includes alcoholic or non-alcoholic steatohepatitis, drug-induced, or ischemic hepatitis.[7]

Kidney and Acute Inflammation

The most common cause of acute kidney inflammation is an infection, ischemia/reperfusion, immune complex formation, or
complement dysregulation. The most important promoters of kidney inflammation are the epithelial cells of the renal tubules that
secrete cytokines in response to the inducers. These mediators activate the pathways NF-kB or MAPK.[18]

Intestinal tract and Acute Inflammation

Acute inflammatory diseases of the intestinal tract can decrease patients' quality of life worldwide. Polygenic inflammatory bowel
disease (IBDs) is characterized by an excessive inflammatory response to gut microbial flora. IBDs include Crohn disease (CD) and
ulcerative colitis (UC). These two diseases are cytokine driven. Apart from that, other causes include non-infectious inflammation of the

https://www.ncbi.nlm.nih.gov/books/NBK556083/ Página 3 de 5
Acute Inflammatory Response - StatPearls - NCBI Bookshelf 13/02/22, 18:45

bowel. The system can recognize the microbial agent through the TLRs. These PAMPs that bind to the TLRs (mainly TLR4) activate
the signaling pathways (NF-kB, MAPK) that cause the production of cytokines and chemokines to start the resistance to the infection.
[19]

Clinical Significance
There are five cardinal signs of inflammation, namely redness (rubor), heat (calor), swelling (tumor), pain (dolor), and loss of function
(functio laesa). The sensation of heat is caused by the increased blood movement in dilated vessels into environmentally cooled
extremities. This reaction will also lead to redness due to an increase in the number of erythrocytes passing through the injured area. The
swelling of the area occurs due to an increase in the permeability and dilatation of the blood vessels. Pain is due to an increase in the
pain mediators, either due to direct damage or resulting from an inflammatory response itself. Loss of function occurs due to either
simple loss of mobility due to either edema or pain or replacement of the cells with scar tissue.[20]

Review Questions
Access free multiple choice questions on this topic.
Comment on this article.

References
1. Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-
1beta generation. Clin Exp Immunol. 2007 Feb;147(2):227-35. [PMC free article: PMC1810472] [PubMed: 17223962]
2. Pahwa R, Goyal A, Bansal P, Jialal I. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Sep 28, 2021. Chronic
Inflammation. [PubMed: 29630225]
3. Germolec DR, Shipkowski KA, Frawley RP, Evans E. Markers of Inflammation. Methods Mol Biol. 2018;1803:57-79. [PubMed:
29882133]
4. Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008 Jul 24;454(7203):428-35. [PubMed: 18650913]
5. Varela ML, Mogildea M, Moreno I, Lopes A. Acute Inflammation and Metabolism. Inflammation. 2018 Aug;41(4):1115-1127.
[PubMed: 29404872]
6. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell. 2010 Mar 19;140(6):771-6. [PubMed: 20303867]
7. Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. Inflammatory responses and inflammation-associated
diseases in organs. Oncotarget. 2018 Jan 23;9(6):7204-7218. [PMC free article: PMC5805548] [PubMed: 29467962]
8. Brennan JJ, Gilmore TD. Evolutionary Origins of Toll-like Receptor Signaling. Mol Biol Evol. 2018 Jul 01;35(7):1576-1587.
[PubMed: 29590394]
9. Takeda K, Akira S. Toll-like receptors. Curr Protoc Immunol. 2015 Apr 01;109:14.12.1-14.12.10. [PubMed: 25845562]
10. Wenzel SE. Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy. 1997 Jan-Feb;17(1 Pt 2):3S-
12S. [PubMed: 9017783]
11. Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, Asadi S, Vasiadi M, Weng Z, Miniati
A, Kalogeromitros D. Mast cells and inflammation. Biochim Biophys Acta. 2012 Jan;1822(1):21-33. [PMC free article:
PMC3318920] [PubMed: 21185371]
12. Haddad A, Wilson AM. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Sep 5, 2021. Biochemistry, Complement.
[PubMed: 31334949]
13. Bardhan M, Kaushik R. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): May 9, 2021. Physiology, Complement
Cascade. [PubMed: 31855355]
14. Jukema BN, de Maat S, Maas C. Processing of Factor XII during Inflammatory Reactions. Front Med (Lausanne). 2016;3:52.
[PMC free article: PMC5095611] [PubMed: 27867935]
15. Schmaier AH. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities. J Thromb Haemost.
2016 Jan;14(1):28-39. [PubMed: 26565070]

https://www.ncbi.nlm.nih.gov/books/NBK556083/ Página 4 de 5
Acute Inflammatory Response - StatPearls - NCBI Bookshelf 13/02/22, 18:45

16. Stone WL, Basit H, Burns B. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Dec 4, 2020. Pathology,
Inflammation. [PubMed: 30521241]
17. Manohar M, Verma AK, Venkateshaiah SU, Sanders NL, Mishra A. Pathogenic mechanisms of pancreatitis. World J Gastrointest
Pharmacol Ther. 2017 Feb 06;8(1):10-25. [PMC free article: PMC5292603] [PubMed: 28217371]
18. Poveda J, Sanz AB, Rayego-Mateos S, Ruiz-Ortega M, Carrasco S, Ortiz A, Sanchez-Niño MD. NFκBiz protein downregulation in
acute kidney injury: Modulation of inflammation and survival in tubular cells. Biochim Biophys Acta. 2016 Apr;1862(4):635-646.
[PubMed: 26776679]
19. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007 Mar;117(3):514-21. [PMC
free article: PMC1804356] [PubMed: 17332878]
20. Punchard NA, Whelan CJ, Adcock I. The Journal of Inflammation. J Inflamm (Lond). 2004 Sep 27;1(1):1. [PMC free article:
PMC1074343] [PubMed: 15813979]

Publication Details

Author Information

Authors

Sally Hannoodee1; Dian N. Nasuruddin2.

A!liations
1
Albert Einstein Healthcare Network/Einstein Medical Center Montgomery
2 Universiti Kebangsaan Malaysia

Publication History

Last Update: November 21, 2021.

Copyright
Copyright © 2022, StatPearls Publishing LLC.

This book is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits
use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, a
link is provided to the Creative Commons license, and any changes made are indicated.

Publisher

StatPearls Publishing, Treasure Island (FL)

NLM Citation

Hannoodee S, Nasuruddin DN. Acute Inflammatory Response. [Updated 2021 Nov 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022
Jan-.

https://www.ncbi.nlm.nih.gov/books/NBK556083/ Página 5 de 5